Triamcinolone Dosage for Post-Rhinoplasty Supratip Fullness
For supratip fullness after rhinoplasty, inject triamcinolone acetonide at a concentration of 10 mg/mL (diluted from 40 mg/mL stock), with 0.2-0.4 mL per session, starting no earlier than 4 weeks post-surgery, repeated at 4-6 week intervals for 2-4 total sessions as needed.
Concentration and Volume
The most recent systematic review evidence supports 10 mg/mL as the optimal concentration 1. This is typically achieved by diluting the standard 40 mg/mL triamcinolone acetonide suspension with sterile saline. The guideline evidence for acne nodules suggests concentrations of 5-10 mg/mL for soft tissue inflammatory conditions 2, which aligns with rhinoplasty applications.
Volume per session should be 0.2-0.4 mL maximum 3, 4. Larger volumes increase the risk of skin atrophy, depigmentation, and telangiectasias. One study using 8 mg/mL and 16 mg/mL found no significant difference between concentrations, suggesting that lower concentrations within the therapeutic range are equally effective 5.
Timing and Injection Schedule
Begin injections at 4 weeks post-rhinoplasty at the earliest 1. Starting earlier risks interfering with normal healing. One study initiated treatment at 1 week post-surgery 4, but more recent evidence favors waiting until the 4-week mark to allow initial healing 1, 6.
Repeat injections every 4-6 weeks based on clinical response 1, 6, 3. Most patients require 2-4 total injection sessions. In one series, 73% of patients received injections, with 72% requiring a second injection at 4 weeks, and 85% achieving acceptable results 4.
Injection Technique
Inject subcutaneously in the deep subcutaneous tissue, not intradermally 3. The injection should be placed just beneath the dermis in the upper subcutis, similar to the technique described for intralesional corticosteroids in other conditions 7, 8. Intradermal injection significantly increases the risk of skin atrophy and visible complications.
Target the supratip area specifically where fullness is present. The recent FAN (Fine Administered Needle) technique describes a single subcutaneous injection at the nasal tip to ensure optimal distribution 9.
Expected Response and Duration
Effects appear within 7-14 days and last approximately 4-6 weeks 1. This explains why repeat injections are typically needed at 4-6 week intervals. If no favorable response occurs within 6-8 weeks of the first injection, consider repeating the injection before pursuing surgical revision 3.
Patient Selection
This approach is most effective for soft tissue pollybeak deformities caused by subdermal scarring and fibrosis, not for structural issues 4. If supratip fullness results from inadequate cartilage resection, overresected midvault, or inadequate tip projection (pseudodeformity), surgical correction is required rather than steroid injection 3.
Patients with thick or reactive soft tissue envelopes benefit most from this treatment 1, 9. Histopathologic studies show significant fibrosis in supratip soft tissue of secondary rhinoplasty patients, making them particularly good candidates 3.
Critical Safety Considerations
Do not inject if there is any concern for vascular compromise. Recent case reports document nasal ischemia and necrosis following triamcinolone injection, likely from arterial embolization or vasospasm 10. While rare, this represents a serious complication requiring immediate intervention with hyaluronidase, platelet-rich fibrin, and potentially hyperbaric oxygen therapy.
Avoid injection at sites of active infection 2. The immunosuppressive effects of corticosteroids can worsen infections.
Common minor side effects include local atrophy, pigmentary changes, and telangiectasias when excessive volumes or concentrations are used 2. These are dose-dependent and can be minimized by adhering to recommended volumes and concentrations.
Alternative Approach for Non-Responders
If steroid injection fails after 2-4 sessions over 3-6 months, proceed to surgical revision with direct excision of recalcitrant soft tissue excess and approximation of subcutaneous tissue to underlying cartilage 3. Intralesional steroid injection should be considered first-line treatment before revision surgery, as revision is technically difficult and carries additional risks 4.
Contraindications to Injection
Do not inject if:
- Supratip fullness is due to structural cartilage issues rather than soft tissue (requires surgical correction)
- Active infection is present
- Previous hypersensitivity to triamcinolone
- Signs of vascular compromise or skin blanching occur during injection